Small intestinal bacterial overgrowth recurrence after antibiotic therapy - PubMed (original) (raw)
. 2008 Aug;103(8):2031-5.
doi: 10.1111/j.1572-0241.2008.02030.x.
Maurizio Gabrielli, Emidio Scarpellini, Andrea Lupascu, Marialuisa Novi, Sandra Sottili, Giovanna Vitale, Valentina Cesario, Michele Serricchio, Giovanni Cammarota, Giovanni Gasbarrini, Antonio Gasbarrini
Affiliations
- PMID: 18802998
- DOI: 10.1111/j.1572-0241.2008.02030.x
Small intestinal bacterial overgrowth recurrence after antibiotic therapy
Ernesto C Lauritano et al. Am J Gastroenterol. 2008 Aug.
Abstract
Objectives: Current treatment for small intestinal bacterial overgrowth (SIBO) is based on courses of broad-spectrum antibiotics. No data concerning SIBO recurrence are available. The aims of the present study were to investigate SIBO recurrence as assessed by glucose breath test (GBT) after antibiotic treatment and conditions associated to SIBO recurrence.
Methods: Eighty consecutive patients affected by SIBO and decontaminated by rifaximin (1,200 mg per day for 1 wk) were enrolled. Diagnosis of SIBO was based on GBT. GBT was reassessed at 3, 6, and 9 months after evidence of GBT normalization. GBT positivity recurrence, predisposing conditions, and gastrointestinal symptoms were evaluated.
Results: Ten (10/80, 12.6%), 22 (22/80, 27.5%), and 35 (35/80, 43.7%) patients showed positivity to GBT at 3, 6, and 9 months after successful antibiotic treatment, respectively. At multivariate analysis, older age (OR 1.09, 95% CI 1.02-1.16), history of appendectomy (OR 5.9, 95% CI 1.45-24.19), and chronic use of proton pump inhibitors (PPIs) (OR 3.52, 95% CI 1.07-11.64) were significantly associated to GBT positivity recurrence. All gastrointestinal symptoms significantly increased at 3, 6, and 9 months in patients with evidence of GBT positivity recurrence.
Conclusions: GBT positivity recurrence rate was high after antibiotic treatment. Older age, history of appendectomy, and chronic use of PPIs were associated with GBT positivity recurrence. Patients with evidence of GBT positivity recurrence showed gastrointestinal symptoms relapse thus suggesting SIBO recurrence.
Similar articles
- Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
Lombardo L, Foti M, Ruggia O, Chiecchio A. Lombardo L, et al. Clin Gastroenterol Hepatol. 2010 Jun;8(6):504-8. doi: 10.1016/j.cgh.2009.12.022. Epub 2010 Jan 6. Clin Gastroenterol Hepatol. 2010. PMID: 20060064 - Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
Weinstock LB, Geng B, Brandes SB. Weinstock LB, et al. Can J Urol. 2011 Aug;18(4):5826-30. Can J Urol. 2011. PMID: 21854715 Clinical Trial. - Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
Aziz I, Törnblom H, Simrén M. Aziz I, et al. Curr Opin Gastroenterol. 2017 May;33(3):196-202. doi: 10.1097/MOG.0000000000000348. Curr Opin Gastroenterol. 2017. PMID: 28257307 Review. - Diagnosis of small intestinal bacterial overgrowth in the clinical practice.
Gabrielli M, D'Angelo G, Di Rienzo T, Scarpellini E, Ojetti V. Gabrielli M, et al. Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:30-5. Eur Rev Med Pharmacol Sci. 2013. PMID: 24443065 Review.
Cited by
- How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
Skrzydło-Radomańska B, Cukrowska B. Skrzydło-Radomańska B, et al. J Clin Med. 2022 Oct 12;11(20):6017. doi: 10.3390/jcm11206017. J Clin Med. 2022. PMID: 36294338 Free PMC article. Review. - What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea?
O'Brien L, Wall CL, Wilkinson TJ, Gearry RB. O'Brien L, et al. Nutrients. 2021 Apr 21;13(5):1393. doi: 10.3390/nu13051393. Nutrients. 2021. PMID: 33919083 Free PMC article. Review. - Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL, DuPont HL. Koo HL, et al. Curr Opin Gastroenterol. 2010 Jan;26(1):17-25. doi: 10.1097/MOG.0b013e328333dc8d. Curr Opin Gastroenterol. 2010. PMID: 19881343 Free PMC article. Review. - Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use.
Saadi M, McCallum RW. Saadi M, et al. Ther Adv Chronic Dis. 2013 Mar;4(2):71-5. doi: 10.1177/2040622312472008. Ther Adv Chronic Dis. 2013. PMID: 23556126 Free PMC article. - Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea.
Playford RJ, Choudhry N, Kelly P, Marchbank T. Playford RJ, et al. Nutrients. 2021 Mar 22;13(3):1024. doi: 10.3390/nu13031024. Nutrients. 2021. PMID: 33809940 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical